Slack J D
Angiology. 1981 Aug;32(8):567-80. doi: 10.1177/000331978103200807.
Clinicians have puzzled over the coronary physiology associated with atypical angina pectoris for the past century. Recent recognition of coronary artery spasm, which has been so thoroughly documented with coronary angiography, has resolved many of these conceptual difficulties. However, several features of coronary artery spasm, both spontaneous and secondary to provocation with ergonovine maleate, remain poorly understood. This paper addresses the management problems associated with spontaneously occurring spasm in the setting of pre-existent atherosclerotic coronary artery disease, angiographically severe spasm unassociated with symptoms of angina pectoris or signs of myocardial ischemia, and the precipitation of angina pectoris by ergonovine maleate administration unaccompanied by demonstrable epicardial coronary artery spasm. The rationale, indications and therapeutic efficacy of a new class of agents known as slow channel inhibitors of calcium antagonists are discussed.
在过去的一个世纪里,临床医生一直对与非典型心绞痛相关的冠状动脉生理学感到困惑。最近对冠状动脉痉挛的认识,已通过冠状动脉造影得到了充分记录,解决了许多此类概念上的难题。然而,冠状动脉痉挛的几个特征,无论是自发性的还是因马来酸麦角新碱激发继发的,仍了解甚少。本文探讨了在已存在动脉粥样硬化性冠状动脉疾病的情况下,与自发性痉挛相关的管理问题;血管造影显示严重痉挛但与心绞痛症状或心肌缺血体征无关的情况;以及给予马来酸麦角新碱后诱发心绞痛但未伴有可证实的心外膜冠状动脉痉挛的情况。还讨论了一类称为钙拮抗剂慢通道抑制剂的新型药物的理论基础、适应症和治疗效果。